Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

ALXN

ALEXION PHARMACEUTICALS INC

ALXN·015351109·US·Common Stock

ALXN (ALEXION PHARMACEUTICALS INC) is held by 2 institutional investors as of Q3 2021. Top institutional shareholders: Orion Porfolio Solutions, LLC ($423,000), BARCLAYS PLC ($22,000).

2
Holders
$445,000
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold ALXN.

Top Holders

Checking access…
Action
Unchanged
2,302$423,0000.0%—
0
Decreased
6(-100.0%)$22,0000.0%—
0
Exited
0(-100.0%)$249M0.0%—
0
Exited
0(-100.0%)$726,0000.0%—
0
Exited
0(-100.0%)$69.4M0.0%—
0
Exited
0(-100.0%)$124.7M0.0%—
0
Exited
0(-100.0%)$200,0000.0%—
0
Exited
0(-100.0%)$887.2M0.0%—
0
Exited
0(-100.0%)$141.2M0.0%—
0
Exited
0(-100.0%)$8.4M0.0%—
0
Exited
0(-100.0%)$16.9M0.0%—
0
Exited
0(-100.0%)$230,0000.0%—
0
Exited
0(-100.0%)$357,0000.0%—
0
Exited
0(-100.0%)$19.4M0.0%—
0
Exited
0(-100.0%)$569,0000.0%—
0
Exited
0(-100.0%)$9.5M0.0%—
0
Exited
0(-100.0%)$39.7M0.0%—
0
Exited
0(-100.0%)$218,0000.0%—
0
Exited
0(-100.0%)$617,0000.0%—
0
Exited
0(-100.0%)$790,0000.0%—
0

Showing 1-20 of 233

1 / 12
ALXNALXNALEXION PHARMACEUTICALS INC

Similar stocks

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used